Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

National practice patterns and preferences in the use of fixed-duration vs. treat-to-progression therapies for CLL

Tisheeka Graham, Tariqa Ackbarali, Catherine Coombs, John Allan

Blood (2025) 146 (Supplement 1): 8095.

https://doi.org/10.1182/blood-2025-8095

Published: 2025

Journal Articles

Uncovering practice gaps in the management of mantle cell and diffuse large B-cell lymphomas amidst advances with Bruton's tyrosine kinase inhibitors

Tisheeka Graham, Tariqa Ackbarali, Katie Kowalski, Anita Kumar, Matthew Matasar, Caron Jacobson, Kami Maddocks

Blood (2025) 146 (Supplement 1): 8106.

https://doi.org/10.1182/blood-2025-8106

Published: 2025

Journal Articles

Integrating bispecific antibodies into community myeloma care: Challenges, insights, and educational impact

Tisheeka Graham, Tariqa Ackbarali, Krina Patel, Joshua Richter

Blood (2025) 146 (Supplement 1): 8134.

https://doi.org/10.1182/blood-2025-8134

Published: 2025

Journal Articles

Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies

Tisheeka Graham, Tariqa Ackbarali, Katie Kowalski, Sharon M. Castellino, Lisa Giulino Roth, Matthew J. Ehrhardt, Matthew Matasar

Blood (2024) 144 (Supplement 1): 7794.

https://doi.org/10.1182/blood-2024-211680

Published: 2024

Journal Articles

Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma

Tisheeka Graham, Tariqa Ackbarali, Anita Kumar, Matthew Matasar

Blood (2024) 144 (Supplement 1): 7785.

https://doi.org/10.1182/blood-2024-208930

Published: 2024

Journal Articles

Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers

Tisheeka Graham, Tariqa Ackbarali, Chijioke Nze, Ashley Bryant, Adolfo Diaz Duque, Christopher R. Flowers

Blood (2023) 142 (Supplement 1): 2388.

https://doi.org/10.1182/blood-2023-180181

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

National practice patterns and preferences in the use of fixed-duration vs. treat-to-progression therapies for CLL

Uncovering practice gaps in the management of mantle cell and diffuse large B-cell lymphomas amidst advances with Bruton's tyrosine kinase inhibitors

Integrating bispecific antibodies into community myeloma care: Challenges, insights, and educational impact

Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies

Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma

Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers

Email alerts

ASH Publications

American Society of Hematology

Update search

National practice patterns and preferences in the use of fixed-duration vs. treat-to-progression therapies for CLL

Uncovering practice gaps in the management of mantle cell and diffuse large B-cell lymphomas amidst advances with Bruton's tyrosine kinase inhibitors

Integrating bispecific antibodies into community myeloma care: Challenges, insights, and educational impact

Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies

Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma

Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only